Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-May-24 5:06 PM View:  | Iqvia Holdings Inc. (IQV) | 07-May-24 | Grant | 1,047 | -- | -- | 8% 12.74K to 13.78K | |
| 05-Mar-24 4:10 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-24 | Grant | 113,586 | -- | -- | 13% 904.9K to 1.02M | |
| 05-Jan-24 4:51 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jan-24 | Sale | 19,223 | $29.46 | $566,310.00 | (2%) 924.12K to 904.9K | |
| 03-Jan-24 5:30 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-24 | Option Exercise | 7,848 | -- | -- | < 1% 916.28K to 924.12K | |
| 12-May-23 5:20 PM View: | Iqvia Holdings Inc. (IQV) | 10-May-23 | Grant | 1,063 | -- | -- | 9% 11.67K to 12.74K | |
| 03-Mar-23 5:18 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-23 | Grant | 91,036 | -- | -- | 11% 825.24K to 916.28K | |
| 06-Jan-23 5:32 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Jan-23 | Sale | 6,673 | $37.21 | $248,302.00 | (< 1%) 831.91K to 825.24K | |
| 04-Jan-23 8:36 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-23 | Option Exercise | 7,848 | -- | -- | < 1% 824.07K to 831.91K | |
| 13-May-22 5:02 PM View: | Iqvia Holdings Inc. (IQV) | 11-May-22 | Grant | 995 | -- | -- | 9% 10.68K to 11.67K | |
| 04-Mar-22 9:07 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-22 | Grant | 40,990 | -- | -- | 5% 783.08K to 824.07K | |
| 04-Mar-22 9:07 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Exercise | 7,848 | -- | -- | 1% 777.72K to 785.57K | |
| 04-Mar-22 9:07 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Sale | 2,493 | $112.25 | $279,852.00 | (< 1%) 785.57K to 783.08K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Sep-21 | Option Exercise | 44,735 | $21.62 | $967,000.00 | 6% 777.72K to 822.46K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Sep-21 | Market Option Sale (Planned) | 44,735 | $170.00 | $7,604,950.00 | (5%) 822.46K to 777.72K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Aug-21 | Option Exercise | 37,833 | $14.58 | $551,605.00 | 5% 777.72K to 815.55K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Aug-21 | Market Option Sale (Planned) | 37,833 | $155.00 | $5,864,120.00 | (5%) 815.55K to 777.72K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Option Exercise | 38,804 | $14.23 | $552,031.00 | 5% 777.72K to 816.52K | |
| 01-Sep-21 8:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Market Option Sale (Planned) | 38,804 | $155.95 | $6,051,350.00 | (5%) 816.52K to 777.72K | |
| 25-Aug-21 4:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 23-Aug-21 | Option Exercise | 27,139 | $13.40 | $363,663.00 | 3% 777.72K to 804.86K | |
| 25-Aug-21 4:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 23-Aug-21 | Market Option Sale (Planned) | 27,139 | $152.01 | $4,125,420.00 | (3%) 804.86K to 777.72K | |
| 20-Aug-21 6:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 19-Aug-21 | Option Exercise | 22,682 | $13.40 | $303,939.00 | 3% 777.72K to 800.4K | |
| 20-Aug-21 6:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 19-Aug-21 | Market Option Sale (Planned) | 22,682 | $151.28 | $3,431,400.00 | (3%) 800.4K to 777.72K | |
| 19-Apr-21 5:04 PM View: | Iqvia Holdings Inc. (IQV) | 15-Apr-21 | Grant | 934 | -- | -- | 10% 9.74K to 10.68K | |
| 15-Apr-21 8:50 PM View: | Intellia Therapeutics, Inc. (NTLA) | 13-Apr-21 | Option Exercise | 25,937 | $11.16 | $289,506.00 | 3% 751.78K to 777.72K | |
| 02-Apr-21 8:46 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Apr-21 | Option Exercise | 71,041 | $14.15 | $1,005,050.00 | 10% 718.95K to 789.99K | |
| 02-Apr-21 8:46 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Apr-21 | Market Option Sale (Planned) | 38,209 | $83.64 | $3,195,660.00 | (5%) 789.99K to 751.78K | |
| 09-Feb-21 8:36 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Feb-21 | Option Exercise | 56,718 | $6.83 | $387,384.00 | 8% 690.28K to 746.99K | |
| 09-Feb-21 8:36 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Feb-21 | Market Option Sale (Planned) | 28,043 | $75.00 | $2,103,220.00 | (4%) 746.99K to 718.95K | |
| 09-Feb-21 8:36 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Feb-21 | Option Exercise | 40,000 | $13.40 | $536,000.00 | 6% 673.22K to 713.22K | |
| 09-Feb-21 8:36 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Feb-21 | Market Option Sale (Planned) | 22,942 | $67.66 | $1,552,190.00 | (3%) 713.22K to 690.28K | |
| 03-Feb-21 9:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Feb-21 | Option Exercise | 117,060 | $17.68 | $2,069,790.00 | 19% 624.01K to 741.07K | |
| 03-Feb-21 9:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Feb-21 | Market Option Sale (Planned) | 67,856 | $72.54 | $4,922,490.00 | (9%) 741.07K to 673.22K | |
| 03-Feb-21 9:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Feb-21 | Option Exercise | 200,000 | $13.69 | $2,737,600.00 | 37% 533.9K to 733.9K | |
| 03-Feb-21 9:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Feb-21 | Market Option Sale (Planned) | 109,889 | $64.00 | $7,032,900.00 | (15%) 733.9K to 624.01K | |
| 05-Jan-21 9:24 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Jan-21 | Market Option Sale | 6,239 | $55.86 | $348,511.00 | (1%) 540.14K to 533.9K | |
| 05-Jan-21 9:24 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Dec-20 | Option Exercise | 14,375 | -- | -- | 3% 525.77K to 540.14K | |
| 27-Nov-20 9:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 27-Nov-20 | Option Exercise | 35,000 | $16.17 | $566,100.00 | 7% 525.77K to 560.77K | |
| 27-Nov-20 9:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 27-Nov-20 | Market Option Sale (Planned) | 35,000 | $38.57 | $1,350,000.00 | (6%) 560.77K to 525.77K | (61%) |
| 25-Nov-20 8:02 PM View: | Intellia Therapeutics, Inc. (NTLA) | 25-Nov-20 | Option Exercise | 50,000 | $6.83 | $341,500.00 | 10% 525.77K to 575.77K | |
| 25-Nov-20 8:02 PM View: | Intellia Therapeutics, Inc. (NTLA) | 25-Nov-20 | Market Option Sale (Planned) | 50,000 | $36.00 | $1,800,000.00 | (9%) 575.77K to 525.77K | (73%) |
| 18-Nov-20 7:56 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Nov-20 | Option Exercise | 20,000 | $14.58 | $291,600.00 | 4% 525.77K to 545.77K | (1%) |
| 18-Nov-20 7:56 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Nov-20 | Market Option Sale (Planned) | 20,000 | $34.00 | $680,000.00 | (4%) 545.77K to 525.77K | (83%) |
| 06-Nov-20 4:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Nov-20 | Option Exercise | 50,000 | $6.83 | $341,500.00 | 10% 525.77K to 575.77K | |
| 06-Nov-20 4:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Nov-20 | Market Option Sale (Planned) | 50,000 | $26.00 | $1,300,000.00 | (9%) 575.77K to 525.77K | (139%) |
| 09-Oct-20 4:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 07-Oct-20 | Option Exercise | 5,000 | $6.83 | $34,150.00 | < 1% 525.77K to 530.77K | |
| 09-Oct-20 4:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 07-Oct-20 | Market Option Sale (Planned) | 5,000 | $21.83 | $109,150.00 | (< 1%) 530.77K to 525.77K | (185%) |
| 03-Sep-20 4:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Sep-20 | Option Exercise | 5,000 | $6.83 | $34,150.00 | < 1% 525.77K to 530.77K | |
| 03-Sep-20 4:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Sep-20 | Market Option Sale (Planned) | 5,000 | $21.83 | $109,150.00 | (< 1%) 530.77K to 525.77K | (185%) |
| 07-Aug-20 7:29 PM View: | Intellia Therapeutics, Inc. (NTLA) | 06-Aug-20 | Option Exercise | 5,000 | $6.83 | $34,150.00 | < 1% 525.77K to 530.77K | |
| 07-Aug-20 7:29 PM View: | Intellia Therapeutics, Inc. (NTLA) | 06-Aug-20 | Market Option Sale (Planned) | 5,000 | $21.83 | $109,150.00 | (< 1%) 530.77K to 525.77K | (185%) |